tiprankstipranks

Matthew R. Henn Insider Profile

11 Followers
Matthew R. Henn, Chief Scientific Officer and EVP at Seres Therapeutics, holds 63.44K shares in Seres Therapeutics (Ticker: MCRB).
tipranks
Matthew R. Henn

Matthew R. Henn
Seres Therapeutics (MCRB)
Chief Scientific Officer and EVP

Not Ranked
Matthew R. Henn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$74K
100.00%
A breakdown of Matthew R. Henn's holdings

Insider Roles

Seres Therapeutics
(MCRB)
Chief Scientific Officer and EVP
Roles that Matthew R. Henn holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Matthew R. Henn

Matthew R. Henn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Seres Therapeutics
Feb 16, 2024
Chief Scientific Officer and EVP
Uninformative Sell
4.50K
$73.59K
Matthew R. Henn has not reported any informative transactions for MCRB, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 28, 2020
Uninformative Buy
$0.00
-
$0.00
Jul 06, 2022
Uninformative Buy
$150.00K
-
$3.15
Oct 31, 2023
Uninformative Sell
$5.25K
-
$0.00
Feb 16, 2024
Uninformative Sell
$4.50K
-
$0.00
List of latest transactions for each holding click on a transaction to see Matthew R. Henn's performance on stock

Matthew R. Henn insider profile FAQ

What is the percentage of profitable transactions made by Matthew R. Henn?
The percentage of profitable transactions made by Matthew R. Henn is ―.
    What is the average return per transaction made by Matthew R. Henn?
    The average return per transaction made by Matthew R. Henn is ―.
      What stocks does Matthew R. Henn hold?
      Matthew R. Henn holds: MCRB stocks.
        What was Matthew R. Henn’s latest transaction?
        Matthew R. Henn latest transaction was an Uninformative Sell of $4.50K.
          What was Matthew R. Henn's most profitable transaction?
          Matthew R. Henn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Matthew R. Henn's role in Seres Therapeutics?
            Matthew R. Henn's role in Seres Therapeutics is Chief Scientific Officer and EVP.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.